close
This ad will auto close in 10 seconds
Germany suspends marketing of 54 drugs tested by India's GVK Bio

Germany suspends marketing of 54 drugs tested by India's GVK Bio

Germany has suspended marketing of 54 drugs tested by GVK Biosciences in compliance with the European Union's ban on around 700 generic drugs.

EU suspends sale of 700 generic drugs made in India

European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU`s executive confirmed on Monday.

Pharmexcil sees $1.2 billion export hit from EU ban

India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.

Inexpensive generic heart disease drugs may treat Ebola

Generic drugs used to treat heart diseases also have the potential to bolster the immune systems of patients with Ebola virus and some other life-threatening illnesses, research has found.

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Endo to buy Par Pharmaceutical for $8.05 billion

Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo`s generic drugs business, the companies said Monday.

India may take WTO action against EU over drug clinical trials: GVK

The privately-held company, part of India`s infrastructure builder GVK Group, conducts clinical research for domestic and foreign drugmakers.

Maharashtra doctors ordered to prescribe generic drugs

Maharashtra doctors have been ordered to prescribe generic drugs for affordable medicines.

'Indian pharma firms must innovate in face of generic drugs slowdown'

Indian pharmaceuticals companies need to diversify their product range and focus on evolving as innovators as growth in generic market is expected to slow down over the next decade, a study by industry body Assocham said on Monday.

Novartis profits jump 12% on new drug sales

Novartis profits jump 12% on new drug sales

Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

Probing manufacture of generic drugs without testing: Nadda

The government is investigating reports of generic versions of some medicines being manufactured without proper testing, Health Minister J.P. Nadda Friday told parliament.

Medicine prices have reduced: Ananth Kumar

The government Thursday insisted that the prices of medicines had come down under the Narendra Modi government over the last six months and said that it was committed to encourage the use of generic drugs.

GVK Bio offers to re-do studies after EU ruling

Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.

France, Germany suspend some drug approvals over Indian data

All of the drugs being suspended, several of which are manufactured by Mylan Inc and Abbott , have brand name equivalents that can be used instead, so patients will not have to interrupt their treatment.

US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs

Drug firm Ranbaxy Laboratories on Wednesday said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.

US denies Ranbaxy's bid to block launch of rival generics

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral, a court filing showed.

US court overturns bid by Ranbaxy to block launch of rival generic drugs

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral Valcyte.

Indian drugmakers see US sales hit by delay in new approvals

Leading Indian generic drugmakers Dr Reddy`s Laboratories Ltd and Glenmark Pharmaceuticals Ltd this month posted a drop in their second-quarter US sales

Supreme Court to examine issue of alleged non-availability of drugs

The Supreme Court has issued a notice to Centre to examine the issue of alleged non availability of generic drugs and vaccines.

Lupin launches generic Ciprofloxacin in US market

The company had earlier received final approval for the product from the USFDA.